Search Tag: GT Medical Technologies
2024 15 Apr
GT Medical Technologies, Inc. (GT MedTech) announces the successful acquisition of Cesium-131 and related assets from Isoray Medical, a subsidiary of Perspective Therapeutics, Inc. This acquisition solidifies GT MedTech's position as sole manufacturer of Cesium-131 brachytherapy seeds for cancer treatments. The completion of the acquisition...Read more
2023 16 Mar
GT Medical Technologies, Inc. has appointed Michael A. Garcia , MD, MS, as its Chief Medical Officer. In his new role, Dr. Garcia will expand the GammaTile ® Therapy clinical study pipeline, support research and development, lead medical affairs, and promote additional efforts for expanding the evidence-based use of GammaTile Therapy and its incorporation...Read more